Zura Bio Ltd
ZURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855644
No open-market purchases or sales by Zura Bio Ltd insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $428.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Zura Bio Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q4 2023
- Shares held
- 14.9M
- −281.3K (−1.9%) vs. Q4 2023
- Total value
- $37.6M
- −$33.1M (−46.8%) vs. Q4 2023
- New holders
- 5
- 14 more added
- Sold out
- 4
- 19 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $428.9M |
| Q1 2026 | 94 | $391.8M |
| Q4 2025 | 75 | $235.1M |
| Q3 2025 | 69 | $179.2M |
| Q2 2025 | 65 | $37.1M |
| Q1 2025 | 74 | $59.0M |
| Q4 2024 | 87 | $107.2M |
| Q3 2024 | 78 | $151.1M |
| Q2 2024 | 57 | $114.9M |
| Q1 2024 | 45 | $37.6M |
| Q4 2023 | 44 | $70.7M |
| Q3 2023 | 41 | $93.3M |
| Q2 2023 | 38 | $105.0M |
| Q1 2023 | 3 | $24.7K |
| Q4 2022 | 35 | $87.4M |
| Q3 2022 | 33 | $84.2M |
| Q2 2022 | 36 | $77.7M |
| Q1 2022 | 34 | $58.1M |
| Q4 2021 | 25 | $48.5M |
| Q3 2021 | 17 | $31.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Zura Bio Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Advisors, Ltd. LLC | 33 | $0 | 0.00% | +33 | New |
| Impact Partnership Wealth, LLC | 6 | $15 | 0.00% | −194−97.0% | Reduced |
| Amalgamated Bank | 256 | $1.00K | 0.00% | −406−61.3% | Reduced |
| Ameritas Investment Partners, Inc. | 626 | $1.61K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 1,500 | $4.00K | 0.00% | −100−6.3% | Reduced |
| California State Teachers Retirement System | 1,934 | $4.97K | 0.00% | −870−31.0% | Reduced |
| FMR LLC | 2,962 | $7.61K | 0.00% | +1,769+148.3% | Added |
| Citigroup Inc | 3,195 | $8.21K | 0.00% | +683+27.2% | Added |
| Tower Research Capital LLC (TRC) | 4,307 | $11.1K | 0.00% | +1,584+58.2% | Added |
| Wells Fargo & Company | 6,102 | $15.7K | 0.00% | +773+14.5% | Added |
| JPMorgan Chase & Co | 7,284 | $18.7K | 0.00% | −4,946−40.4% | Reduced |
| American International Group, Inc. | 8,396 | $21.6K | 0.00% | −72−0.9% | Reduced |
| New York State Common Retirement Fund | 8,547 | $22.0K | 0.00% | +49+0.6% | Added |
| Eisler Capital (US) LLC | 100,000 | $27.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,500 | $30.0K | 0.00% | −300−2.5% | Reduced |
| Barclays PLC | 12,336 | $31.7K | 0.00% | −11,275−47.8% | Reduced |
| Bank of America Corp | 14,354 | $36.9K | 0.00% | −10,756−42.8% | Reduced |
| Rhumbline Advisers | 15,523 | $39.9K | 0.00% | +556+3.7% | Added |
| UBS Group AG | 17,232 | $44.3K | 0.00% | +17,232 | New |
| Occudo Quantitative Strategies LP | 19,042 | $48.9K | 0.01% | −1,744−8.4% | Reduced |
| Calamos Advisors LLC | 200,000 | $54.0K | 0.00% | +200,000 | New |
| Invesco Ltd. | 21,456 | $55.1K | 0.00% | −98,984−82.2% | Reduced |
| Morgan Stanley | 22,160 | $57.0K | 0.00% | −36,324−62.1% | Reduced |
| Nuveen Asset Management, LLC | 23,657 | $60.8K | 0.00% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 25,090 | $64.5K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 28,702 | $73.8K | 0.01% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 38,999 | $85.6K | 0.00% | −39,000−50.0% | Reduced |
| Forefront Analytics, LLC | 34,038 | $87.5K | 0.04% | +12,809+60.3% | Added |
| Bank of New York Mellon Corp | 40,697 | $104.6K | 0.00% | −710−1.7% | Reduced |
| Jane Street Group, LLC | 53,117 | $136.5K | 0.00% | +53,117 | New |
| Atom Investors LP | 94,982 | $244.1K | 0.03% | +48,714+105.3% | Added |
| Raymond James & Associates | 111,347 | $286.2K | 0.00% | +33,452+42.9% | Added |
| Northern Trust Corp | 172,717 | $443.9K | 0.00% | +2,540+1.5% | Added |
| Charles Schwab Investment Management Inc | 183,242 | $470.9K | 0.00% | +4,230+2.4% | Added |
| State Street Corp | 214,748 | $551.9K | 0.00% | +23,738+12.4% | Added |
| Silverarc Capital Management, LLC | 328,504 | $844.3K | 0.24% | −134,493−29.0% | Reduced |
| Affinity Asset Advisors, LLC | 450,009 | $1.16M | 0.19% | +450,009 | New |
| Geode Capital Management, LLC | 487,125 | $1.25M | 0.00% | +437+0.1% | Added |
| Vanguard Group Inc | 575,092 | $1.48M | 0.00% | +20,047+3.6% | Added |
| Citadel Advisors LLC | 681,420 | $1.75M | 0.00% | −11,374−1.6% | Reduced |
| BlackRock Inc. | 1,094,617 | $2.81M | 0.00% | −14,327−1.3% | Reduced |
| Armistice Capital, LLC | 1,648,000 | $4.24M | 0.11% | −176,000−9.6% | Reduced |
| Deep Track Capital, LP | 2,523,000 | $6.48M | 0.19% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,757,740 | $7.09M | 1.10% | −537,260−16.3% | Reduced |
| Suvretta Capital Management, LLC | 2,850,000 | $7.32M | 0.31% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −32,486−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −19,458−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,037−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −9,929−100.0% | Sold out |